Function Health and GRAIL Collaborate to Make Multi-Cancer Early Detection Test More Accessible –

What You Should Know:

– Function Health, a revolutionary health management platform empowering people to live 100 healthy years, announces a collaboration with GRAIL, Inc., a healthcare company whose mission is to detect cancer early when it can be cured, to expand the reach of innovative cancer screening to transform cancer care.

–  Function Health’s 400,000+ members nationwide have access to GRAIL’s Galleri test—a first-of-its-kind, clinically validated multi-cancer early detection (MCED) test that screens for multiple cancers with a simple blood draw—as an add-on to its comprehensive list of 100+ lab tests.

Function Health: Revolutionizing Preventative Care with Comprehensive Lab Testing and Early Cancer Detection

Function Health is a pioneering health platform offering access to over 100 lab tests, enabling individuals to gain comprehensive insights into their overall health—including heart health, hormones, thyroid function, nutrients, toxins, immunity, and autoimmune markers. At $499 annually, the platform provides five times more testing than the average physical, which typically assesses only 19 biomarkers. Unlike traditional methods, it eliminates hidden costs, surprise bills, and insurance complications.

A Groundbreaking Approach to Early Cancer Detection

Function Health has partnered with GRAIL to offer the Galleri test, a multi-cancer early detection tool capable of identifying over 50 types of cancers, including those for which no standard screening exists (e.g., esophageal, pancreatic, ovarian, and liver). Recommended for adults at elevated cancer risk, particularly those aged 50 and older, this test detects cancer “fingerprints” before symptoms arise, offering a critical opportunity for early intervention.

Dr. Mark Hyman, Co-Founder and Chief Medical Officer of Function Health, emphasized the importance of proactive health strategies: “With cancer risks rising, education, early detection, and research are crucial in combatting harmful diseases. By integrating the Galleri test into our platform, we’re enabling members to screen for cancer as part of their annual checkups, enhancing treatment options and outcomes.”

Tackling a Growing Health Crisis

Cancer is projected to affect over two million individuals in the U.S. in 2024, with more than 611,000 lives lost to the disease. Alarmingly, 70% of cancer deaths result from types without recommended screening tests. Function Health’s platform bridges this gap, helping broaden access to early detection technologies like the Galleri test.

Comprehensive Health Insights for Every Member

Function Health members receive:

• Access to 100+ lab tests: Covering cardiovascular, endocrine, and immune health, as well as markers for toxins and autoimmunity.
• Detailed, actionable insights: Generated by leading clinicians and paired with tailored lifestyle recommendations.
• Proactive cancer screening: Early detection through the Galleri test, with success stories already highlighting its life-saving potential.